Review article · 2024 · Open access

Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications

Xuan Pan, ting han, Zixuan Zhao, Xiao Ming Wang, Xiaosan Fang

International Journal of Nanomedicine, Volume 19, 6619–6641 · Published 1 July 2024 · DOI 10.2147/ijn.s466459

Open PDFView at the publisherCite this paper

In brief

“Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications” is a 2024 review article by Xuan Pan and 4 co-authors, published in International Journal of Nanomedicine. OpenAlex counts 7 citations as of 21 November 2026, which puts it in the top 8% of works published in 2024 by citations. It is open access under a CC BY-NC licence: the full text is free to read at International Journal of Nanomedicine.

Citations
7
Most cited in
2026 (5)
Field-weighted impact
0.16
References
130
Authors
5

Abstract

The high malignant degree and poor prognosis of pancreatic cancer (PC) pose severe challenges to the basic research and clinical translation of next-generation therapies. The rise of immunotherapy has improved the treatment of a variety of solid tumors, while the application in PC is highly restricted by the challenge of immunosuppressive tumor microenvironment. The latest progress of nanotechnology as drug delivery platform and immune adjuvant has improved drug delivery in a variety of disease backgrounds and enhanced tumor therapy based on immunotherapy. Based on the immune loop of PC and the status quo of clinical immunotherapy of tumors, this article discussed and critically analyzed the key transformation difficulties of immunotherapy adaptation to the treatment of PC, and then proposed the rational design strategies of new nanocarriers for drug delivery and immune regulation, especially the design of combined immunotherapy. This review also put forward prospective views on future research directions, so as to provide information for the new means of clinical treatment of PC combined with the next generation of nanotechnology and immunotherapy.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Pan, X., han, T., Zhao, Z., Wang, X. M., & Fang, X. (2024). Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications. International Journal of Nanomedicine, Volume 19, 6619–6641. https://doi.org/10.2147/ijn.s466459

MLA 9

Pan, Xuan, et al. “Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications.” International Journal of Nanomedicine, vol. Volume 19, 2024, pp. 6619–6641. https://doi.org/10.2147/ijn.s466459.

Chicago

Pan, Xuan, ting han, Zixuan Zhao, Xiao Ming Wang, and Xiaosan Fang. 2024. “Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications.” International Journal of Nanomedicine Volume 19: 6619–6641. https://doi.org/10.2147/ijn.s466459.

Harvard

Pan, X. et al. (2024) ‘Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications’, International Journal of Nanomedicine, Volume 19, pp. 6619–6641. doi:10.2147/ijn.s466459.

IEEE

X. Pan, T. han, Z. Zhao, X. M. Wang, and X. Fang, “Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications,” International Journal of Nanomedicine, vol. Volume 19, pp. 6619–6641, 2024, doi: 10.2147/ijn.s466459.

BibTeX

@article{pan2024emerging,
  title     = {{Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications}},
  author    = {Pan, Xuan and han, ting and Zhao, Zixuan and Wang, Xiao Ming and Fang, Xiaosan},
  journal   = {International Journal of Nanomedicine},
  year      = {2024},
  volume    = {Volume 19},
  pages     = {6619--6641},
  doi       = {10.2147/ijn.s466459},
  url       = {https://doi.org/10.2147/ijn.s466459}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery

  • pancreatic cancer
  • cancer immunotherapy
  • nanotechnology
  • nanocarriers
  • drug delivery
  • immunoadjuvant
  • immunosuppressive tumor microenvironment
  • combination immunotherapy

Work with this paper

Most-cited papers in Materials Science

All highly cited Materials Science papers

Questions about this paper

How do I cite this paper in APA style?

Pan, X., han, T., Zhao, Z., Wang, X. M., & Fang, X. (2024). Emerging Nanotechnology in Preclinical Pancreatic Cancer Immunotherapy: Driving Towards Clinical Applications. International Journal of Nanomedicine, Volume 19, 6619–6641. https://doi.org/10.2147/ijn.s466459

How many times has this paper been cited?

7 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Nanomedicine: sign in and open the PDF from this page.

Who wrote this paper?

Xuan Pan, ting han, Zixuan Zhao, Xiao Ming Wang, Xiaosan Fang.

What is the DOI of this paper?

10.2147/ijn.s466459, permanently at https://doi.org/10.2147/ijn.s466459. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.